Assessing adherence to direct oral anticoagulants (DOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

QR Code

Assessing adherence to direct oral anticoagulants (DOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

INTRODUCTION Direct oral anticoagulants (DOACs), such as dabigatran and rivaroxaban, are now available for stroke prevention in patients with atrial fibrillation (AF) and are often clinically preferred over vitamin K antagonists (VKAs), such as warfarin. Data describing adherence to DOACs in real-...

Full description

Bibliographic Details
Main Authors:	Kubas, Mohammed Abdullah, Shabaruddin, Fatiha Hana, Mazlan-Kepli, Wardati, Jagan, Nirmala, Mohamed, Sahimi, Mohamed Nazar, Nor Ilyani, Zin, Che Suraya
Format:	Proceeding Paper
Language:	English English English
Published:	2019
Subjects:	RM Therapeutics. Pharmacology
Online Access:	http://irep.iium.edu.my/75874/ http://irep.iium.edu.my/75874/1/191104_main%20page_program.pdf http://irep.iium.edu.my/75874/2/191104_kubas_poster_program.pdf http://irep.iium.edu.my/75874/3/191015_poster%20icprp_Kubas_ICPRP_A0_v05.pdf

Similar Items

Assessing adherence and persistence to non-vitamin k antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed A., et al.
Published: (2020)

Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?
by: Alamneh, E., et al.
Published: (2016)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence
by: Gebreyohannes, Eyob Alemayehu, et al.
Published: (2020)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Association between use of non–vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
by: Chang, Shang-Hung, et al.
Published: (2017)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Assessment Of Medication Adherence, Knowledge, And Health-Related Quality Of Life Among Atrial Fibrillation Patients Using Warfarin In Penang, Malaysia
by: Matalqah, Laila Mahmoud Ali
Published: (2014)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation
by: Koya Kutty, Shahedah, et al.
Published: (2018)

Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care
by: Taggar, Jaspal, et al.
Published: (2016)

Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)

Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis
by: Mohd, Noor Norhayati, et al.
Published: (2020)

Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis
by: Taggar, Jaspal S., et al.
Published: (2015)

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Filion, K., et al.
Published: (2011)